Chiron Investment Management LLC acquired a new position in shares of Elanco Animal Health (NASDAQ:ELAN) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 5,000 shares of the company’s stock, valued at approximately $158,000.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Focused Wealth Management Inc purchased a new stake in Elanco Animal Health during the fourth quarter worth about $32,000. First Hawaiian Bank purchased a new position in shares of Elanco Animal Health in the fourth quarter worth about $35,000. Citigroup Inc. increased its stake in shares of Elanco Animal Health by 28.2% in the fourth quarter. Citigroup Inc. now owns 5,389 shares of the company’s stock worth $169,000 after purchasing an additional 1,187 shares in the last quarter. Krensavage Asset Management LLC increased its stake in shares of Elanco Animal Health by 0.7% in the fourth quarter. Krensavage Asset Management LLC now owns 201,362 shares of the company’s stock worth $6,162,000 after purchasing an additional 1,362 shares in the last quarter. Finally, American International Group Inc. purchased a new position in shares of Elanco Animal Health in the fourth quarter worth about $48,000.
In related news, Director R David Hoover bought 20,000 shares of the company’s stock in a transaction on Wednesday, March 13th. The stock was acquired at an average cost of $31.43 per share, for a total transaction of $628,600.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
ELAN stock opened at $30.31 on Friday. Elanco Animal Health has a 12 month low of $28.00 and a 12 month high of $37.61.
Elanco Animal Health (NASDAQ:ELAN) last released its quarterly earnings data on Wednesday, February 6th. The company reported $0.29 EPS for the quarter, beating analysts’ consensus estimates of $0.26 by $0.03. The firm had revenue of $799.30 million during the quarter, compared to the consensus estimate of $804.07 million. During the same quarter last year, the business posted $0.12 earnings per share. Elanco Animal Health’s revenue was up 6.0% compared to the same quarter last year.
About Elanco Animal Health
There is no company description available for Elanco Animal Health Inc
Read More: Stop Order Uses For Individual Investors
Want to see what other hedge funds are holding ELAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elanco Animal Health (NASDAQ:ELAN).
Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.